Biotech and drug stocks
7.45k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop speciality drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three-month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called ‘Battling Cancer’.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| Biotech and drug stocks | +0.46% | - | - | - |
| ^GSPC | +0.13% | -0.28% | +25.36% | +5478.17% |
31 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | 777.77 | +11.09 | +1.45% | 4:00 pm GMT-4 | 2.84M | 2.95M | 739.20B |
| NVO | Novo Nordisk A/S | 127.29 | +2.70 | +2.17% | 4:00 pm GMT-4 | 4.07M | 4.79M | 567.85B |
| JNJ | Johnson & Johnson | 148.72 | +0.14 | +0.09% | 4:00 pm GMT-4 | 6.90M | 7.63M | 357.92B |
| MRK | Merck & Co., Inc. | 130.38 | +2.81 | +2.20% | 4:00 pm GMT-4 | 6.65M | 8.21M | 330.23B |
| ABBV | AbbVie Inc. | 162.55 | -0.18 | -0.11% | 4:00 pm GMT-4 | 5.28M | 5.70M | 287.04B |
| AZN | AstraZeneca PLC | 76.32 | +0.56 | +0.74% | 4:00 pm GMT-4 | 5.73M | 6.57M | 236.63B |
| NVS | Novartis AG | 99.07 | +1.34 | +1.37% | 4:00 pm GMT-4 | 1.15M | 1.62M | 202.14B |
| RHHBY | Roche Holding AG | 30.48 | +0.39 | +1.30% | 4:00 pm GMT-4 | 1.12M | 2.85M | 197.00B |
| AMGN | Amgen Inc. | 300.3 | +0.82 | +0.27% | 4:00 pm GMT-4 | 2.44M | 2.92M | 161.09B |
| PFE | Pfizer Inc. | 27.77 | -0.39 | -1.38% | 4:00 pm GMT-4 | 61.16M | 41.86M | 157.25B |
| SNY | Sanofi | 49.57 | +0.24 | +0.49% | 4:00 pm GMT-4 | 1.22M | 2.08M | 123.75B |
| REGN | Regeneron Pharmaceuticals, Inc. | 969.97 | +11.33 | +1.18% | 4:00 pm GMT-4 | 358.70k | 468.77k | 106.88B |
| VRTX | Vertex Pharmaceuticals Incorporated | 410.24 | +7.74 | +1.92% | 4:00 pm GMT-4 | 1.61M | 1.04M | 106.03B |
| GSK | GSK plc | 44.15 | +0.70 | +1.61% | 4:00 pm GMT-4 | 2.93M | 3.36M | 90.08B |
| BMY | Bristol-Myers Squibb Company | 44.04 | +0.14 | +0.32% | 4:00 pm GMT-4 | 10.92M | 15.60M | 89.27B |
| GILD | Gilead Sciences, Inc. | 65.46 | -0.08 | -0.12% | 4:00 pm GMT-4 | 5.90M | 7.32M | 81.63B |
| ZTS | Zoetis Inc. | 168.45 | +2.50 | +1.51% | 4:00 pm GMT-4 | 3.32M | 3.73M | 76.86B |
| MRNA | Moderna, Inc. | 121.07 | -1.06 | -0.87% | 4:00 pm GMT-4 | 2.85M | 3.99M | 46.40B |
| TAK | Takeda Pharmaceutical Company Limited | 13.28 | -0.08 | -0.60% | 4:00 pm GMT-4 | 1.73M | 1.63M | 41.88B |
| HLN | Haleon plc | 8.33 | +0.09 | +1.09% | 4:00 pm GMT-4 | 5.28M | 6.08M | 38.19B |
| BIIB | Biogen Inc. | 218.92 | -2.50 | -1.13% | 4:00 pm GMT-4 | 1.16M | 1.31M | 31.87B |
| BAYRY | Bayer Aktiengesellschaft | 7.72 | +0.11 | +1.45% | 3:59 pm GMT-4 | 1.27M | 2.07M | 30.34B |
| ARGX | argenx SE | 398.81 | +5.03 | +1.28% | 4:00 pm GMT-4 | 203.71k | 263.48k | 23.70B |
| BNTX | BioNTech SE | 90.88 | -2.47 | -2.65% | 4:00 pm GMT-4 | 480.63k | 606.98k | 21.90B |
| ALNY | Alnylam Pharmaceuticals, Inc. | 154.33 | +3.11 | +2.06% | 4:00 pm GMT-4 | 337.37k | 814.27k | 19.52B |
| GMAB | Genmab A/S | 29.29 | +0.26 | +0.90% | 4:00 pm GMT-4 | 675.01k | 561.00k | 18.92B |
| ALPMY | Astellas Pharma Inc. | 10.05 | -0.01 | -0.14% | 3:59 pm GMT-4 | 594.25k | 326.13k | 18.16B |
| BGNE | BeiGene, Ltd. | 160.56 | -1.92 | -1.18% | 4:00 pm GMT-4 | 108.71k | 215.06k | 17.75B |
| RPRX | Royalty Pharma plc | 28.28 | -0.21 | -0.74% | 4:00 pm GMT-4 | 2.39M | 2.83M | 16.90B |
| TEVA | Teva Pharmaceutical Industries Limited | 13.95 | -0.11 | -0.78% | 4:00 pm GMT-4 | 13.10M | 9.18M | 15.80B |
- Reuters
UPDATE 2-Pfizer reports patient death in Duchenne gene therapy study
A young patient died due to cardiac arrest after receiving Pfizer's experimental gene therapy being tested in a mid-stage trial for a muscle-wasting disorder called Duchenne muscular dystrophy(DMD), the drugmaker told Reuters on Tuesday. "A fatal serious adverse event was reported as cardiac arrest for a participant in the Phase 2 DAYLIGHT study," a company spokesperson told Reuters in an emailed response. The trial is testing boys 2 to three years of age with DMD, a genetic muscle wasting disorder in which most patients lack the protein dystrophin which keeps muscles intact.
GlobeNewswireargenx announces results of Annual General Meeting of Shareholders
May 7, 2024 – 5:30pm ET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the results of its Annual General Meeting of shareholders held today. All items on the agenda received a majority of votes in favor except for agenda item 5 (adoption of the remuneration policy). As part of the approved resolutions: The Company's annual report and annual accounts for t
- Reuters
UPDATE 1-AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports
Anglo-Swedish drugmaker AstraZeneca is withdrawing its COVID-19 vaccine worldwide, the Telegraph reported on Tuesday. The vaccine can no longer be used in the European Union after the company voluntarily withdrew its "marketing authorisation", the report stated. The application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the report, which added that similar applications would be made in the UK and other countries that had approved the vaccine, known as Vaxzevria, in the coming months.
